Journal of Affective Disorders
Volume 76, Issue 1 , Pages 267-271 , September 2003

Efficacy and tolerability of quetiapine in the treatment of bipolar disorder: preliminary evidence from a 12-month open-label study

  • A.C. Altamura

      Affiliations

    • Department of Psychiatry, University of Milan School of Medicine, Department of Clinical Sciences, Ospedale “Luigi Sacco”, Via G.B. Grassi 74, 20157 Milan, Italy
    • Corresponding Author InformationCorresponding author. Tel.: +39-2-3904-2904; fax: +39-2-3904-2510
    • ,
  • Daniele Salvadori

      Affiliations

    • Department of Psychiatry, University of Milan School of Medicine, Department of Clinical Sciences, Ospedale “Luigi Sacco”, Via G.B. Grassi 74, 20157 Milan, Italy
    • ,
  • Donato Madaro

      Affiliations

    • Department of Psychiatry, University of Milan School of Medicine, Department of Clinical Sciences, Ospedale “Luigi Sacco”, Via G.B. Grassi 74, 20157 Milan, Italy
    • ,
  • Annalisa Santini

      Affiliations

    • Department of Psychiatry, University of Milan School of Medicine, Department of Clinical Sciences, Ospedale “Luigi Sacco”, Via G.B. Grassi 74, 20157 Milan, Italy
    • ,
  • Emanuela Mundo

      Affiliations

    • Department of Psychiatry, University of Milan School of Medicine, Department of Clinical Sciences, Ospedale “Luigi Sacco”, Via G.B. Grassi 74, 20157 Milan, Italy

Received 29 October 2001 ,Revised 11 February 2002 ,Accepted 15 February 2002.

References 

  1. Altamura AC, Madaro D, Salvadori D. Quetiapine in acute mania: a case report with 6-month follow-up. Int. J. Psych. Clin. Pract. 2001;5:283–285
  2. Dunayevich E, Strakowski SM. Quetiapine in treatment-resistant mania: a case report. Am. J. Psychatry. 2000;157(8):1341
  3. Ghaemi SN, Katzow JJ. The use of quietapine for treatment-resistant bipolar disorder: a case series. Ann. Clin. Psychiatry. 1999;11(3):137–140
  4. Guy W. ECDEU Assessment Manual for Psychopharmacology. DHEW Publication no. 76-338 (ABM). Washington, DC: Government Printing Office; 1976;
  5. Hamilton M. Rating depressive patients. J. Clin. Psychiatry. 1980;41(12):21–24
  6. Hammer MB, Goldstein J. Acute and long-term effects of quetiapine on plasma prolactin levels. In: Presented at Schizophrenia and beyond. Montreaux, Switzerland, 20–21 June. 2001;
  7. McElroy SL, Keck PE. Pharmacologic agents for the treatment of acute bipolar mania. Biol. Psychiatry. 2000;48(6):539–557
  8. Sajatovic M, Brescan D, Perez D, Di Giovanni S. Quetiapine in the treatment of neuroleptic-dependent mood disorders. In: Presented at the World Psychiatric Association, XI World Congress of Psychiatry, Hamburg, Germany, Aug 6–11. 1999;
  9. Woerner MG, Mannuzza S, Kane JM. Anchoring the BPRS: an aid to improved reliability. Psychophar. Bull. 1988;24(1):112–117
  10. Young RC, Biggs JT, Ziegler VE, Meyer DA. A rating scale for mania: reliability, validity and sensitivity. Br. J. Psychiatry. 1978;133:429–435

PII: S0165-0327(02)00075-7

doi: 10.1016/S0165-0327(02)00075-7

Journal of Affective Disorders
Volume 76, Issue 1 , Pages 267-271 , September 2003

Article Tools